Reply: Effect of populationbased screening on breast cancer mortality

The Lancet

Volumn 379, Issue 9823, 2012, Pages 1297-

  Gøtzsche, Peter C ^a   Jørgensen, Karsten J ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL EFFECTIVENESS; FEMALE; HUMAN; LETTER; MAMMOGRAPHY; PRIORITY JOURNAL; BREAST TUMOR; MASS SCREENING; MORTALITY; NOTE; ADVANCED CANCER; BREAST EXAMINATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURGERY; CLINICAL TRIAL (TOPIC); CONSULTATION; HEALTH PROGRAM; MASTECTOMY; MEDICAL INFORMATION; POPULATION RESEARCH; PRACTICE GUIDELINE; SYMPTOM;

BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING;

EID: 84859317754     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60039-7     Document Type: Letter

References (5)

1. Bock K, Borisch B, Cawson J, et al. Effect of population-based screening on breast cancer mortality. Lancet 2011; 378: 1775-76.
2. Jørgensen KJ, Keen JD, Gøtzsche PC. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor Effect on mortality? Radiology 2011; 260: 621-27.
3. Canadian Task Force for Preventive Health Care. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ 2011; 183: 1991-2001.
4. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2009; 4: CD001877.
5. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009; 339: b2587.